Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era

Toshihito Onda(Juntendo University), Hiroyuki Daida(Juntendo University Hospital), Iwao Okai(Juntendo University Nerima Hospital), Takatoshi Kasai(Juntendo University), Satoru Suwa(Juntendo University Shizuoka Hospital), Masataka Sumiyoshi(Juntendo University Nerima Hospital), Jo Matsuoka(Juntendo University Hospital), Yuji Nishizaki(Juntendo University), Kentaro Fukuda(Juntendo University Nerima Hospital), Kenji Inoue(Juntendo University Nerima Hospital), Yasumasa Fujiwara(Juntendo University Nerima Hospital), Yuki Kimura(Jichi Medical University)
International Journal of Cardiology
June 19, 2016
10.1016/j.ijcard.2016.06.014
Cited by 16

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells
|Cell stem cell|2010|670
T Cell-Specific Loss of Pten Leads to Defects in Central and Peripheral Tolerance
|Immunity|2001|594
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
|Journal of Atherosclerosis and Thrombosis|2013|469